Latest filing published 05 May 2026 for AMGEN INC, €210k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Peter H. Griffith is a declared insider of Amgen Inc (finance chief), with filings sourced from SEC (Form 4). Over a trading history stretching from 30 April 2021 to 2 May 2026, the count stands at 27 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The latest filing, published on 5 May 2026, reports a share grant of €193k in Amgen Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 27 declarations